Search results for "SCALE"

showing 10 items of 5180 documents

Associated factors to psychiatric morbidity in postmenopausal phases.

1998

Abstract Background: The greatest risk of psychiatric morbidity during the climacteric years is linked to a greater exposure to stressful life experiences, women's dissatisfaction with their role in society and to an absence of social backup. The question to be posed now is the extent to which the longitudinal surveys can confirm, refute or complement the results of the cross-sectional analyses. Methods: A study involving population-based cohorts was carried out on a sample of 120 women who had been previously identified as being premenopausal or menopausal during a cross-sectional examination conducted between 1987 and 1988 within the city of Valencia (Spain). The aims were to analyze the …

medicine.medical_specialtyCross-sectional studyPopulationGeneral Biochemistry Genetics and Molecular BiologyCohort StudiesLife Change EventsSocial supportConfidence IntervalsOdds RatioMedicineHumansPsychiatryeducationPsychiatric Status Rating Scaleseducation.field_of_studybusiness.industrySocial changeObstetrics and GynecologyGender IdentitySocial SupportOdds ratioMiddle AgedPostmenopauseCross-Sectional StudiesLogistic ModelsSocial ClassSpainFemalebusinessClimactericPsychosocialCohort studyFollow-Up StudiesMaturitas
researchProduct

Oral Health Scales: Design of an Oral Health Scale of Infectious Potential

2013

Objectives: In this paper we propose a new Global Oral Health Scale that will allow the infectious potential of the oral cavity, clinically manifest as local and focal infections, to be condensed into a single parameter. Study Design: Based on a number of oral health scales previously designed by our group, we designed a final version that incorporates dental and periodontal variables (some of them evaluated using corroborated objective indices) that reflect the presence of caries and periodontal disease. Results: The application of the proposed oral health scale requires the examination of 6 sites per tooth (mesio- buccal, medio-buccal, disto-buccal, disto-lingual, medio-lingual and mesio-…

medicine.medical_specialtyDentistryOdontologíaOral HealthOral healthOral cavityRisk Assessmentstomatognathic systemPeriodontal diseaseEpidemiologyHumansMedicineGingival inflammationGeneral DentistryFinal versionbusiness.industrySingle parameterBacterial Infections:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludstomatognathic diseasesOtorhinolaryngologyScale (social sciences)UNESCO::CIENCIAS MÉDICASResearch-ArticleOdontostomatology for the Disabled or Special PatientsSurgerybusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Evaluating the neurotoxic effects of lactational exposure to persistent organic pollutants (POPs) in Spanish children.

2012

Although the brain continues developing in the postnatal period, epidemiological studies on the effects of postnatal exposure to neurotoxic POPs through breast-feeding remain mostly inconclusive. Failure to detect associations between postnatal exposure and health outcomes may stem from the limitations of commonly employed approaches to assess lactational exposure. The aim of the present study was to assess whether lactational exposure to polychlorinated biphenyl-153 (PCB-153), dichlorodiphenyldichloroethylene (DDE), or hexachlorobenzene (HCB) as estimated with a physiologically based pharmacokinetic (PBPK) model, is associated with decrements in mental and psychomotor development scores of…

medicine.medical_specialtyDichlorodiphenyl DichloroethyleneBreastfeedingPhysiologyNeuropsychological TestsToxicologyBayley Scales of Infant DevelopmentModels BiologicalRisk AssessmentDevelopmental psychologychemistry.chemical_compoundChild DevelopmentCognitionPregnancyRisk FactorsEpidemiologymedicineHexachlorobenzeneHumansLactationPsychomotor learningPregnancyMilk Humanbusiness.industryGeneral NeuroscienceAge FactorsInfant NewbornBrainInfantHexachlorobenzenemedicine.diseasePolychlorinated BiphenylsBreast FeedingchemistryDichlorodiphenyldichloroethyleneMaternal ExposureSpainPrenatal Exposure Delayed EffectsLinear ModelsPopulation studyEnvironmental PollutantsFemaleNeurotoxicity SyndromesbusinessPsychomotor PerformanceNeurotoxicology
researchProduct

Second to fourth digit ratio (2D:4D) of the right hand is associated with nociception and augmenting-reducing

2008

The ratio of the length of the second and fourth fingers (2D:4D) represents an individual difference variable putatively related to prenatal testosterone exposure. Previous research found significant associations between this variable and sexually dimorphic and other sex-hormone mediated traits like fertility, masculinity, spatial ability and sensation seeking. The present study aimed to relate digit ratio to pain perception using electric pain stimuli. 131 volunteers (69 females) participated. Two electric stimuli of different intensity were applied to the forearm. Digit ratio was obtained from the left and right hands and pain tolerance was assessed by means of visual analog scales. Addit…

medicine.medical_specialtyDigit ratioVisual analogue scalePain tolerancemedia_common.quotation_subjectSpatial abilityAudiologyStimulus (physiology)Developmental psychologyNociceptionPerceptionmedicineSensation seekingPsychologyGeneral Psychologymedia_commonPersonality and Individual Differences
researchProduct

Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research

2017

Executive summary A concerted effort to tackle the global health problem posed by traumatic brain injury (TBI) is long overdue. TBI is a public health challenge of vast, but insufficiently recognised, proportions. Worldwide, more than 50 million people have a TBI each year, and it is estimated that about half the world’s population will have one or more TBIs over their lifetime. TBI is the leading cause of mortality in young adults and a major cause of death and disability across all ages in all countries, with a disproportionate burden of disability and death occurring in low-income and middle-income countries (LMICs). It has been estimated that TBI costs the global economy approximately $…

medicine.medical_specialtyEVIDENCE-BASED MEDICINETreatment outcomePoison controlOther Research Radboud Institute for Molecular Life Sciences [Radboudumc 0]EMERGENCY-DEPARTMENT VISITSReviewPLACEBO-CONTROLLED TRIALMiddle income countryHealthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18]03 medical and health sciences0302 clinical medicineIntensive careBrain Injuries TraumaticJournal Articlemedicinetraumatic barin injuryHumans030212 general & internal medicineClinical careNeurologic diseasePsychiatryDIAGNOSTIC MANAGEMENT STRATEGIESbusiness.industryRANDOMIZED CONTROLLED-TRIALACUTE SUBDURAL-HEMATOMASEVERE HEAD-INJURYROAD TRAFFIC INJURIESbrain injuryHospital care3. Good healthReconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10]Brain InjuriesHealth care costPATIENT-REPORTED OUTCOMESHuman medicineNeurology (clinical)businessHumanities030217 neurology & neurosurgeryGLASGOW COMA SCALE
researchProduct

Assessment and management of agitation in psychiatry: Expert consensus

2016

International audience; BACKGROUND:Psychomotor agitation is associated with different psychiatric conditions and represents an important issue in psychiatry. Current recommendations on agitation in psychiatry are not univocal. Actually, an improper assessment and management may result in unnecessary coercive or sedative treatments. A thorough and balanced review plus an expert consensus can guide assessment and treatment decisions.METHODS:An expert task force iteratively developed consensus using the Delphi method. Initial survey items were based on systematic review of the literature. Subsequent surveys included new, re-worded or re-rated items.RESULTS:Out of 2175 papers assessing psychomo…

medicine.medical_specialtyEmergency Medical ServicesConsensusPsychomotor agitationassessmentDelphi methodverbal de-escalation03 medical and health sciencesBenzodiazepines0302 clinical medicineMeta-Analysis as TopicRisk FactorsmedicineHumansPsychiatryPsychomotor AgitationBiological PsychiatryAgitation assessment psychiatric emergency restraint verbal de-escalationRandomized Controlled Trials as TopicPsychiatric Status Rating ScalesPsychiatryAgitationTask forceExpert consensusDisease ManagementEvidence-based medicinepsychiatric emergency3. Good health030227 psychiatryAgitation; assessment; psychiatric emergency; restraint; verbal de-escalation; Biological Psychiatry; Psychiatry and Mental HealthOlanzapinePsychiatry and Mental Healthrestraint[SDV.MHEP.PSM]Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental healthPractice Guidelines as TopicTreatment decision makingmedicine.symptomBiological psychiatryPsychology030217 neurology & neurosurgeryAntipsychotic Agents
researchProduct

Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register)

2021

Purpose: To evaluate clinical features, treatments, and outcomes of osteoporotic patients admitted to internal medicine and geriatric wards compared with non-osteoporotic patients (REPOSI registry). Methods: We studied 4714 patients hospitalized between 2010 and 2016. We reported age, sex, educational level, living status, comorbidities and drugs taken, Cumulative Illness Rating Scale (CIRS), Barthel Index, Short-Blessed Test, 4-item Geriatric Depression Scale, serum hemoglobin, creatinine, and clinical outcomes. Osteoporosis was defined based on the diagnoses recorded at admission, according to the following ICD9: 733, 805-813, 820-823. Results: Twelve percent of the patients had a preadmi…

medicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentOsteoporosis030209 endocrinology & metabolismNO03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEndocrinologyRating scaleInternal medicineDiabetes mellitusVitamin D and neurologyInternal MedicineMedicineeracturesHumansBisphosphonateMedical diagnosisbisphosphonates; eractures; osteoporosis; vitamin DVitamin DAgedCreatinineRehabilitationLS7_9Bisphosphonates; Fractures; Osteoporosis; Vitamin D.business.industryOsteoporosiBisphosphonatesmedicine.diseaseHospitalizationFracturechemistryItaly030220 oncology & carcinogenesisOsteoporosisGeriatric Depression ScaleVitamin D.businessBisphosphonates; Fractures; Osteoporosis; Vitamin D; Aged; Hospitalization; Humans; Internal Medicine; Italy; Vitamin D; OsteoporosisBisphosphonates; Fractures; Osteoporosis; Vitamin DFractures
researchProduct

A systematic review on regenerative alveolar graft materials in clinical trials

2021

Abstract Background Alveolar cleft grafting is a necessary procedure to restore bone defects. Randomized clinical trials (RCTs) are regarded as a golden standard for investigating the efficacy of treatments. Nevertheless, risk of bias (RoB) can still affect the validity of these trials. We aimed to conduct a systemic review of all control trials (CTs) using regenerative materials for alveolar cleft reconstructions to evaluate their RoB and perform a meta-analysis of new bone formation. Methods Cochrane Oral Health Group's Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (PubMed), EMBASE AND Google Scholar were searched up to October 2020. Thereafter, th…

medicine.medical_specialtyEvidence-based medicineMEDLINElaw.inventionIliumRandomized controlled triallawmedicineAdequacy of methodHumansTissue engineeringBone regenerationAutograftsIntention-to-treat analysisbusiness.industryEvidence-based medicineSDG 10 - Reduced InequalitiesRisk of biasJadad scaleSurgeryBone regenerationClinical trialCleft PalateMeta-analysisRegenerative medicine/dk/atira/pure/sustainabledevelopmentgoals/reduced_inequalitiesSurgeryCell transplantationbusinessAlveolar bone graftingJournal of Plastic, Reconstructive and Aesthetic Surgery
researchProduct

Determinants of Sleepiness at Wheel and Missing Accidents in Patients With Obstructive Sleep Apnea

2021

Study ObjectivesMotor-vehicle crashes are frequent in untreated OSA patients but there is still uncertainty on prevalence as well as physiological or clinical determinants of sleepiness at the wheel (SW) in OSA patients. We assessed determinants of SW or sleepiness related near-miss car accident (NMA) in a group of non-professional drivers with OSA.MethodsA 237 consecutive, treatment-naïve PSG-diagnosed OSA patients (161 males, 53.1 ± 12.6 years) were enrolled. Self-reported SW was assessed by positive answer to the question, “Have you had episodes of falling asleep while driving or episodes of drowsiness at wheel that could interfere with your driving skill in the last year?” Occurrence of…

medicine.medical_specialtyExcessive daytime sleepinessexcessive daytime sleepinelcsh:RC321-571OSAInternal medicinemedicineCOPDIn patientsleepiness at wheellcsh:Neurosciences. Biological psychiatry. NeuropsychiatryOriginal ResearchCOPDbusiness.industryGeneral NeuroscienceEpworth Sleepiness Scaleexcessive daytime sleepinessSleep apneamedicine.diseasesleep apneaSleep timeObstructive sleep apneamedicine.symptombusinessSleep durationNeuroscience
researchProduct

Cyclophosphamide Pulse Therapy after Natalizumab Discontinuation for Multiple Sclerosis: a multicenter study.

2015

Importance: Natalizumab discontinuation induces the recurrence of Multiple Sclerosis (MS) disease activity: Currently no therapeutic approach has been found able to abolish disease reactivation. Objective: To collect data from patients with MS switching from natalizumab to cyclophosphamide. Design: Retrospective multicentre study. Setting: Nine Multiple Sclerosis Centers in Italy. Participants: A total of 47 patients with clinically definite RR-MS switched to cyclophosphamide after natalizumab discontinuation. Two patients were excluded from the analysis because received less than 12 natalizumab infusions. The remaining 45 patients were subdivided into two main groups: Early Treatment (peri…

medicine.medical_specialtyExpanded Disability Status ScaleCyclophosphamidebusiness.industryMultiple sclerosismedicine.diseaseOmicsDiscontinuationMultiple sclerosis; Natalizumab discontinuation; Disease reactivation; Cyclophosphamide; ReboundNatalizumabInternal medicineImmunologymedicineBrain magnetic resonance imagingbusinessAdverse effectmedicine.drug
researchProduct